Drugs in Palliative Care
While palliative care has adopted a holistic approach to treatment, medication driven symptom management ostensibly forms the critical aspect of care. Pharmacological therapy can be extremely complex because these patients often have coexisting medical conditions in addition to symptoms caused by their terminal disease. The resulting polypharmacy can be daunting for professionals and can negatively impact on effectiveness of care. Fully revised and updated, the second edition of Drugs in Palliative Care is a detailed yet concise handbook that will appeal to a variety of healthcare professionals involved in the provision of palliative care and medicines information. Divided into three sections it begins with an overview of pharmacology and prescribing advice then contains over 160 monographs of palliative care drugs, in an easy to use A-Z format.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
9 Adverse activity induction Additional information administration advised not drive affect the activity alfentanil analgesic antidepressants aware that dosage BTcP cancer caution in patients clinically relevant drug Co-administration with drugs Constipation Contraindications and precautions CSCI cyclizine daily Diarrhoea discontinuation Dizziness Dose adjustments Elderly drive or operate Drowsiness Drug interactions Drug interactions Pharmacokinetic duloxetine effects The frequency excreted fentanyl guidance is available haloperidol Headache hepatic impairment Hepatic/renal impairment hypoglycaemia hypokalaemia Hyponatraemia hypotension increased as necessary increased risk induction or inhibition—see inhibition inhibition—see b inside inhibitor Initial dose Injection inside back cover insulin lead to clinically levomepromazine liver metabolite metabolized micrograms midazolam mirtazapine modify reactions morphine narrow therapeutic index Nausea NSAIDs opioid oxycodone pain particularly of drugs pathways may lead Pharmacodynamic Pharmacokinetic Pharmacology plasma concentrations reactions and patients receptors reduced relevant drug interactions renal impairment serotonin syndrome severe hepatic impairment specific guidance symptoms Tablet therapeutic index titrated toxicity tramadol treatment vomiting